RCT: Indirect Pulp Treatment in Primary Molars

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT03770871
Collaborator
(none)
88
1
2
23
3.8

Study Details

Study Description

Brief Summary

This study was conducted to evaluate the clinical and the radiographic success of Dycal and Vitrebond as indirect pulp treatment materials in primary molars.

Condition or Disease Intervention/Treatment Phase
  • Drug: Indirect pulp treatment using Dycal (TM)
  • Drug: Indirect pulp treatment using Vitrebond (TM )
Phase 4

Detailed Description

Evaluation of calcium hydroxide and resin modified glass ionomer liner clinically and radiographically as indirect pulp treatment materials in deep caries in primary molars.

Study Design

Study Type:
Interventional
Actual Enrollment :
88 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Parallel group with 1:1 allocation ratioParallel group with 1:1 allocation ratio
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Double blinded
Primary Purpose:
Treatment
Official Title:
Evaluation of Resin Modified Glass Ionomer Liner (Vitrebond™) Versus Calcium Hydroxide as Indirect Pulp Treatment Material Used in Deep Carious Lesions in Primary Molars: A Randomized Clinical Trial
Actual Study Start Date :
Aug 1, 2016
Actual Primary Completion Date :
Aug 1, 2017
Actual Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: IPT using Dycal (TM )

Indirect pulp treatment; IPT using Dycal (TM ); (2 paste system) by partial caries removal

Drug: Indirect pulp treatment using Dycal (TM)
Partial caries removal and protection of the dental pulp with biocompatible material
Other Names:
  • Indirect pulp capping
  • Drug: Indirect pulp treatment using Vitrebond (TM )
    Partial caries removal and protection of the dental pulp with biocompatible material
    Other Names:
  • Indirect pulp capping
  • Experimental: IPT using Vitrebond (TM )

    Indirect pulp treatment; IPT using Vitrebond (TM );(powder and liquid) by partial caries removal

    Drug: Indirect pulp treatment using Dycal (TM)
    Partial caries removal and protection of the dental pulp with biocompatible material
    Other Names:
  • Indirect pulp capping
  • Drug: Indirect pulp treatment using Vitrebond (TM )
    Partial caries removal and protection of the dental pulp with biocompatible material
    Other Names:
  • Indirect pulp capping
  • Outcome Measures

    Primary Outcome Measures

    1. Number of cases reporting postoperative pain [12 months]

      Presence of postoperative pain following dental treatment through patient questionnaire as a sign of clinical failure

    2. Number of cases reporting swelling [12 months]

      Presence of postoperative swelling following dental treatment through visual examination using hand mirror as a sign of clinical failure

    3. Number of cases reporting sinus [12 months]

      Presence of sinus following dental treatment through visual examination using hand mirror as a sign of clinical failure

    4. Number of cases reporting fistula [12 months]

      Presence of fistula following dental treatment through visual examination using hand mirror as a sign of clinical failure

    5. Number of cases reporting tooth mobility [12 months]

      Presence of abnormal tooth mobility following dental treatment through tactile examination using two hand mirrors as a sign of clinical failure

    Secondary Outcome Measures

    1. Number of cases reporting external root resorption [12 months]

      Occurrence of pathological external root resorption following dental treatment through parallel periapical radiographic examination as a sign of radiographic failure

    2. Number of cases reporting internal root resorption [12 months]

      Occurrence of pathological internal root resorption following dental treatment through parallel periapical radiographic examination as a sign of radiographic failure

    3. Number of cases reporting furcation involvement [12 months]

      Occurrence of pathological internal root resorption following dental treatment through parallel periapical radiographic examination as a sign of radiographic failure

    4. Number of cases reporting widening of periodontal membrane space [12 months]

      Occurrence of widening of periodontal membrane space following dental treatment through parallel periapical radiographic examination as a sign of radiographic failure

    5. Number of cases reporting periapical radiolucency [12 months]

      Occurrence of periapical radiolucency following dental treatment through parallel periapical radiographic examination as a sign of radiographic failure

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    4 Years to 8 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion criteria:

    In compliance with AAPD, 2017 guidelines for pulp therapy "IPT is indicated in a primary tooth with no pulpitis or with reversible pulpitis when the deepest carious dentin is not removed to avoid a pulp exposure. The pulp is judged by clinical and radiographic criteria to be vital and able to heal from the carious insult"

    In addition to:
    I-Subjects:
    1. Medically free children, their parent(s) accepts to sign the informed consent.

    2. Age range from 4-8 years.

    II-Molars:
    1. Presence of at least 1 primary molar with deep carious lesion extending to more than one half of the dentin on radiographic examination (to make the trial regardless of number of carious molars).

    2. Clinically: Normal mobility and normal appearance of gingiva (vital teeth).

    3. Radiographically: Normal roots without physiological resorption, normal lamina dura and normal periodontal membrane space (indicated for IPT).

    Exclusion criteria:
    I-Subjects:
    1. Uncooperative children.

    2. Parents unable to attend follow up visits (even after explaining the importance of recall visits).

    II-Molars:
    1. History of spontaneous pain (to exclude reversible pulpitis).

    2. Clinically: Presence of swelling, sinus, fistula or tooth mobility (to exclude non vital teeth).

    3. Radiographically: Presence of radiolucent lesions at furcation or periapical region or external or internal resorption (to exclude teeth not indicated for IPT).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of Oral and Dental Medicine Cairo Egypt 11553

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: Shereen E Taha, Professor, Cairo University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohamed Farouk Rashed, Researcher assisstant, Cairo University
    ClinicalTrials.gov Identifier:
    NCT03770871
    Other Study ID Numbers:
    • CEBD-CU-2014-11-3
    First Posted:
    Dec 10, 2018
    Last Update Posted:
    Aug 30, 2019
    Last Verified:
    Aug 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by Mohamed Farouk Rashed, Researcher assisstant, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 30, 2019